PFT:PA:PA-Invesco FTSE RAFI US 1000 UCITS ETF EUR (EUR)

ETF | Others |

Last Closing

USD 29.635

Change

+0.09 (+0.30)%

Market Cap

USD 0.50B

Volume

862.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.02 (+0.04%)

USD 61.43B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+3.70 (+0.73%)

USD 12.30B
WRD:PA HSBC ETFs Public Limited Compa..

+0.26 (+0.80%)

USD 9.84B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+1.75 (+0.73%)

USD 8.53B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+3.10 (+0.73%)

USD 7.63B
HHH:PA HSBC ETFs Public Limited Compa..

+0.38 (+0.74%)

USD 6.87B
WLD:PA Lyxor UCITS MSCI World D-EUR

+2.24 (+0.69%)

USD 6.71B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.13 (+0.75%)

USD 6.16B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+2.76 (+0.77%)

USD 4.86B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+1.05 (+0.72%)

USD 4.57B

ETFs Containing PFT:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.68% 72% C 77% C+
Dividend Return N/A 84% B 97% N/A
Total Return N/A 46% F 99% N/A
Trailing 12 Months  
Capital Gain 18.02% 66% D+ 77% C+
Dividend Return N/A 80% B- 98% N/A
Total Return N/A 78% C+ 79% B-
Trailing 5 Years  
Capital Gain 72.50% 76% C+ 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 72.50% 75% C 79% B-
Average Annual (5 Year Horizon)  
Capital Gain 13.89% 78% C+ 75% C
Dividend Return N/A 96% N/A 99% N/A
Total Return N/A 44% F 97% N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A 67% D+ 99% N/A
Risk Adjusted Return N/A 98% N/A 99% N/A
Market Capitalization 0.50B 68% D+ 70% C-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.